MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MRUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MRUS stock forecast, quote, news & analysis

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI Trading Bots for MRUS
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
Related Blogs
APLM

Apollomics (APLM): Assessing the Path to a $26 Technical Target

INKT

MiNK Therapeutics (INKT) Falls -12.4% Over 30 Days as Clinical-Stage Biotech Navigates Volatility

CABA

Analyzing Cabaletta Bio (CABA) and Rapport Therapeutics (RAPP): Contrasting Biotech Strategies

EDIT

ALEC vs EDIT: Two Biotech Stocks Navigating Different Paths

LCTX

Comparing FHTX and LCTX: Biotech Pipeline Strategies After Recent Shifts

View all blogs related to
#Biotechnology
Interesting Articles

What is a Discount Broker?

What is the Price to Sales Ratio (P/S Ratio)?

Should I invest in private placements?

What is the difference between active and passive money management?

What is an Earnings Call?

View all articles
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
MRUS stock forecast, quote, news & analysis